FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology and can be used in pediatric orthopedics for laboratory and clinical diagnosis of idiopathic scoliosis.
EFFECT: invention makes it possible to identify molecular genetic markers of the most complex, rapidly progressing type of adolescent idiopathic scoliosis for the purpose of diagnosis at the preclinical stage.
1 cl, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETERMINING EARLY MANIFESTATIONS OF DORSALGIA IN CHILDREN OF SECONDARY SCHOOL AGE 11-15 YEARS OLD, ASSOCIATED WITH LEAD CONTAMINATION OF BIOLOGICAL MEDIA | 2023 |
|
RU2807895C1 |
| METHOD OF PREDICTING RISK OF IDIOPATHIC SCOLIOSIS DEVELOPMENT IN CHILDREN | 2011 |
|
RU2456925C1 |
| APPLICATION OF DNA-DIAGNOSTICS FOR PRESENCE OF POLYMORPHISM R353Q IN GENE OF FACTOR VII OF BLOOD COAGULATION FOR ESTIMATION OF PREDISPOSITION TO DEVELOPMENT OF HABITUAL NONCARRYING OF PREGNANCY AND METHOD OF PREDISPOSITION ESTIMATION TO THIS DISEASE BY MEANS OF ANALYSIS OF COMBINATION OF POLYMORPHISMS C677T OF GENE MTHFR AND OF GENE R353Q OF FACTOR VII | 2006 |
|
RU2330071C1 |
| METHOD FOR DETECTING GENETIC PREDISPOSITION TO RECURRENT PREGNANCY LOSS | 2012 |
|
RU2532367C2 |
| METHOD OF PREDICTING THE RISK OF OSTEOARTHRITIS OF THE KNEE JOINT IN WOMEN BASED ON MOLECULAR GENETIC TESTING | 2023 |
|
RU2796897C1 |
| METHOD FOR DETECTION OF GENETIC PREDISPOSITION TO DEVELOPING MYOCARIAL INFARCTION IN INDIVIDUALS WITH NO CLINICAL IMPLICATIONS OF ISCHEMIC HEART DISEASE | 2011 |
|
RU2469096C2 |
| METHOD FOR PREDICTING THE DVELOPMENT FOR HYPERTONIC DISEASE ACCORDING TO GENETIC RISK FACTORS | 2005 |
|
RU2287158C1 |
| METHOD OF PREDICTING CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2017 |
|
RU2670689C9 |
| METHOD OF DIAGNOSING APOB POLYMORPHISM CAUSING LETAL GENETIC DEFECT OF HOLSTEIN CATTLE HCD - LACK OF CHOLESTEROL | 2016 |
|
RU2634401C1 |
| METHOD FOR APAF1 POLYMORPHISM DETERMINATION, ASSOCIATED WITH HOLSTEIN CATTLE HH1 FERTILITY HAPLOTYPE | 2016 |
|
RU2614117C1 |
